Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Nature. 2024 Mar;627(8004):656-663. doi: 10.1038/s41586-024-07113-9. Epub 2024 Feb 28.
Understanding the cellular processes that underlie early lung adenocarcinoma (LUAD) development is needed to devise intervention strategies. Here we studied 246,102 single epithelial cells from 16 early-stage LUADs and 47 matched normal lung samples. Epithelial cells comprised diverse normal and cancer cell states, and diversity among cancer cells was strongly linked to LUAD-specific oncogenic drivers. KRAS mutant cancer cells showed distinct transcriptional features, reduced differentiation and low levels of aneuploidy. Non-malignant areas surrounding human LUAD samples were enriched with alveolar intermediate cells that displayed elevated KRT8 expression (termed KRT8 alveolar intermediate cells (KACs) here), reduced differentiation, increased plasticity and driver KRAS mutations. Expression profiles of KACs were enriched in lung precancer cells and in LUAD cells and signified poor survival. In mice exposed to tobacco carcinogen, KACs emerged before lung tumours and persisted for months after cessation of carcinogen exposure. Moreover, they acquired Kras mutations and conveyed sensitivity to targeted KRAS inhibition in KAC-enriched organoids derived from alveolar type 2 (AT2) cells. Last, lineage-labelling of AT2 cells or KRT8 cells following carcinogen exposure showed that KACs are possible intermediates in AT2-to-tumour cell transformation. This study provides new insights into epithelial cell states at the root of LUAD development, and such states could harbour potential targets for prevention or intervention.
要制定干预策略,就需要了解导致早期肺腺癌 (LUAD) 发展的细胞过程。在这里,我们研究了 16 个早期 LUAD 和 47 个匹配的正常肺样本中的 246,102 个单个上皮细胞。上皮细胞包含不同的正常和癌细胞状态,癌细胞之间的多样性与 LUAD 特定的致癌驱动因素密切相关。KRAS 突变癌细胞表现出明显的转录特征,分化减少,非整倍体水平低。人 LUAD 样本周围的非恶性区域富含具有高 KRT8 表达的肺泡中间细胞(此处称为 KRT8 肺泡中间细胞 (KACs)),分化减少,可塑性增加,驱动 KRAS 突变。KACs 的表达谱在肺癌前细胞和 LUAD 细胞中富集,并表示预后不良。在接触烟草致癌剂的小鼠中,KACs 在肺肿瘤出现之前出现,并在致癌剂暴露停止后持续数月。此外,它们获得了 Kras 突变,并在源自肺泡型 2 (AT2) 细胞的富含 KAC 的类器官中对靶向 KRAS 抑制敏感。最后,在致癌剂暴露后对 AT2 细胞或 KRT8 细胞进行谱系标记表明,KACs 可能是 AT2 细胞向肿瘤细胞转化的中间产物。这项研究为 LUAD 发展根源的上皮细胞状态提供了新的见解,这些状态可能包含预防或干预的潜在靶点。